IE00BDZVHG35
IE00BDZVHG35
iShares Nasdaq US Biotechnology UCITS ETF
Loading chart...
Analytics & Allocation
Detailed breakdown by growth drivers, valuation & quality, and asset allocation
Growth Drivers (Estimates)
Largest contributors to earnings and revenue growth
Sectors & Industries
Weight
Avg. Growth
Contribution
Balance Sheet & Financial Health
Aggregated leverage and valuation structure
Weighted P/E
18.18
Weighted Fwd P/E
67.86
Avg P/FCF
28.99
Avg FCF Yield
0.72%
Avg EV / EBITDA
48.96
Avg EV / Revenue
97.45
Avg Price-to-Book (P/B)
17.23
Avg Price-to-Sales (P/S)
114.34
Avg Dividend Yield
0.00%
P/E Compression (Trailing vs Fwd)
+273.34%
Avg Debt-to-Equity (D/E)
147.56%
<50% (53.96%) 50-150% (13.69%) >150% (23.8%) Unreported (8.54%)
Profitability Analysis
250 Holdings CountProfitable 64.82%
Profitable 64.82%
85
Holdings Count (34%)
Unprofitable 35.18%
165
Holdings Count (66%)
ETF Concentration (Cumulative Weight)
Cumulative weight of positions (Lorenz curve)
Top 5
32.8%
Top 10
43.8%
Top 25
62.1%
50% Threshold
Top 14
The top 10 positions account for 43.8% of the portfolio. A healthy balance between a strong core and diversification. The steeper the curve initially rises, the more the largest positions dominate the fund volume.
Geographic Distribution
16 CountriesLoading TopoJSON Map...
0% (No exposure)
Tiers:
Low (0.1%+)
Med (22.0%+)
High (57.2%+)
Top (79.2%+)
Country Breakdown
Max: 88.03%
US US88.03%
NL NL2.24%
GB GB2.19%
IE IE1.66%
CH CH1.45%
DK DK1.13%
FR FR1.07%
DE DE0.81%
CA CA0.75%
LU LU0.09%
AU AU0.06%
ES ES0.06%
CN CN0.05%
IL IL0.03%
BE BE0.03%
TW TW0.01%
Sector Distribution
2 SectorIndustry Distribution
8 IndustriesMarket Cap Distribution
250 Holdings CountMega Cap (> 200B)
(1) 8.57%
Large Cap (10B - 200B)
(29) 56.57%
Mid Cap (2B - 10B)
(69) 24.84%
Small / Micro Cap (< 2B)
(150) 9.73%
Unclassified
(1) 0.00%